871.0000 -4.70 (-0.54%)
NSE Sep 19, 2025 15:31 PM
Volume: 232.5K
 

871.00
-0.54%
Geojit BNP Paribas
Strides reported its Q2FY22 revenue at Rs. 721cr, (4.8% QoQ, -9% YoY), enabled by a bounce back in the other regulated markets which was partially offset by an underperformance in the US markets. US markets (34% of total revenues) witnessed a 17% QoQ/-38% YoY...
Strides Pharma Science Ltd. is trading above its 200 day SMA of 755.0
More from Strides Pharma Science Ltd.
Recommended